|
EFTUD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.23889787317921E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.13219988939761E-10 |
| Normal-vs-Stage2 |
3.959600E-02 |
| Normal-vs-Stage3 |
5.22969999527945E-08 |
| Normal-vs-Stage4 |
1.49519996384129E-09 |
| Stage1-vs-Stage2 |
1.456820E-01 |
| Stage1-vs-Stage3 |
9.140000E-01 |
| Stage1-vs-Stage4 |
5.615600E-02 |
| Stage2-vs-Stage3 |
1.892020E-01 |
| Stage2-vs-Stage4 |
1.088130E-02 |
| Stage3-vs-Stage4 |
5.816300E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.43710043865042E-10 |
| Normal-vs-AfricanAmerican |
1.22399979041177E-10 |
| Normal-vs-Asian |
2.68950000048562E-07 |
| Caucasian-vs-AfricanAmerican |
1.068500E-02 |
| Caucasian-vs-Asian |
1.604620E-01 |
| AfricanAmerican-vs-Asian |
3.790400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.557299999013E-08 |
| Normal-vs-Female |
2.54980481173561E-11 |
| Male-vs-Female |
7.528400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.46149981006261E-10 |
| Normal-vs-Age(41-60Yrs) |
7.34490002152199E-09 |
| Normal-vs-Age(61-80Yrs) |
1.73280000004272E-06 |
| Normal-vs-Age(81-100Yrs) |
3.156300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.893200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.071600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.218400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.121200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.118000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.485000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.106790E-01 |
| Classical-VS-Follicular |
4.60270000002261E-06 |
| Classical-VS-Other |
2.152800E-01 |
| Classical-VS-Normal |
1.60982338570648E-14 |
| Tall-VS-Follicular |
2.171900E-04 |
| Tall-VS-Other |
9.243800E-02 |
| Tall-VS-Normal |
2.76099999974022E-07 |
| Follicular-VS-Other |
6.147400E-01 |
| Follicular-VS-Normal |
1.725430E-01 |
| Other-VS-Normal |
2.868800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.6420000000259E-06 |
| Normal-vs-N1 |
2.298700E-03 |
| N0-vs-N1 |
8.625400E-01 |
|
|
